Swedish pharmaceutical company AstraZeneca has decided to expand its global technology development center (GTC) in Mexico with an investment of 33 million pesos (US$1.6 million), attributing its decision to the easy availability of technology talent in the country.

The expansion will lead to the addition of 90 information technology professionals to the company’s 400-strong workforce in Guadalajara.

AstraZeneca has only two such innovation centers in the world, with the other one located in India. Both the centers, according to Alberto Treviño, Director of the GTC, have employed local people, and have been successful to a great extent in developing technology for the company’s operations.

The innovation center provides IT infrastructure management, application development and maintenance, global project management, and various allied IT services in support of the company’s worldwide operations.

With new technologies, such as artificial intelligence, being a vital tool for discovering medicines, the Swedish company is investing a lot of money in technology. Earlier in January this year, Astrazeneca teamed up with Chinese technology powerhouses Alibaba and Tencent to deliver smart healthcare services through the use of artificial intelligence (AI) and the internet of things (IoT) in China.

At an event organized to inaugurate the expanded facility, José Palacios, Secretary of Economic Development,, thanked AstraZeneca for recognizing Mexico’s technology talent, according to El Diario.